Economic evaluation for pharmaceuticals in Germany.
Jönsson
Bengt
B
D000047:Academies and Institutes / Q000331:legislation & jurisprudence*; D003362:Cost-Benefit Analysis; D003659:Decision Making, Organizational; D016527:Drug Costs; D017850:Economics, Pharmaceutical / Q000331:legislation & jurisprudence*; D005858:Germany; D006801:Humans; D007349:Insurance, Health, Reimbursement / Q000331:legislation & jurisprudence*; D007356:Insurance, Pharmaceutical Services / Q000331:legislation & jurisprudence*; D009313:National Health Programs / Q000191:economics / Q000331:legislation & jurisprudence; D019057:Quality-Adjusted Life Years; D013673:Technology Assessment, Biomedical / Q000191:economics* / Q000331:legislation & jurisprudence